IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IOVA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/21	07:00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/19	07:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/14	07:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/05	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/12/03	07:25	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/27	06:01	GlobeNewswire Inc.	Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/22	07:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	07:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/08	06:01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/11/01	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/10/17	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/06	08:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/09/04	06:00	GlobeNewswire Inc.	Iovance Biotherapeutics to Present at Upcoming Conferences	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/17	06:00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/10	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/09	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/08/09	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/30	05:01	GlobeNewswire Inc.	Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/20	06:00	GlobeNewswire Inc.	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc
2024/07/18	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOVA	Iovance Biotherapeutics Inc